Manuscripts should be prepared using word-processing software. Number all pages consecutively, beginning from the title page, followed by author information, abstract, introduction, materials and methods, results, discussion, acknowledgements, references, figure legends, and figures/tables. For authors from China, one copy of the Chinese translation of the abstract and main content of the manuscript is required. When submitting, authors should provide a cover letter explaining the innovative content of their manuscript, or whether their manuscript is a repetitive verification experiment. Original articles should reflect the essence of experimental or clinical studies. There are more than 5 000 English words in the main body (not including figures, tables and references). The information required for each manuscript is as follows:
The title page should include the full title, all author(s) name(s), institution(s) and/or department(s), correspondence author’s contact information (telephone number and email address), and financial support.
Title: The title should be to the point and present the difference from other papers. It should be diversified, active in presentation mood. The interrogative, rhetoric, rhetorical sentences, and title accompanied by subtitle are encouraged, not limited to the indicative mood.
Authorship: Authorship credit should be in accordance with the standard proposed by international Committee of Medical Journal Editors, based on (1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; and (3) final approval of the version to be published. Authors should meet conditions 1, 2, and 3.
There should be less than 6 authors from one institutional affiliation. Both the first author and corresponding author are required to provide name, year of birth, highest academic degree earned, professional titles, research direction, telephone number, fax number, and e-mail address.
Authors from China should spell their names using Bopomofo. List the author(s) name(s) as follows: initials and/or first name, middle name or initial(s) and full family name. Separate different authors with commas and no full stops after initials, e.g. Wang Li-sha, Liu Kun, Benjamin Shaw. List author(s) job titles and postcodes.
Corresponding author: The name, mailing address, telephone and fax numbers, and e-mail address of the author responsible for correspondence about the manuscript. (The “corresponding author;” this author may or may not be the “guarantor” for the integrity of the study). The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper, and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.
Institution/Affiliation: Include authors’ department, institution, city with postal code, and state/country. Provinces and cities in China are spelled using Bopomofo. “陕西省”and “内蒙古自治区” should be translated into Shaanxi Province and Inner Mongolia Autonomous Region.
Format for financial support: Supported by the National Natural Science Foundation of China, No. 30221803.
Research Highlights are a short collection of bullet points that convey the core findings of the article. Often, they are the main three to five highlights of the article, 200-300 words. Authors can select the points of their research they wish to highlight at article submission stage. Research Highlights will be published above the abstract.
An abstract of about 250 words are commended using the following headings: BACKGROUND, OBJECTIVE, METHODS, RESULTS AND CONCLUSION. The abstract should briefly present the problem investigated and experimental methods, and state the main findings and conclusion.
Please list 5-10 key words which reflect the content of the study.
Provide a context or background for the study (that is, the nature of the problem and its significance). Review briefly the pertinent literature. To lay stress on innovative contents based on previous work. State the specific purpose or research objective of, or hypothesis tested by, the study or observation. Both the main and secondary objectives should be clear, and any prespecified subgroup analyses should be described. Provide only directly pertinent references, and do not include data or conclusions from the work being reported.
Materials and Methods
The material and methods section should be brief but sufficient to allow other investigator to repeat the research. It should provide the following information to readers, which includes:
Design: Scientific research design type.
Time and setting: Time and precise place for experimentation.
Animals/Subjects: General data of experimental animals or subjects involved.
Selection and Description of Participants: Describe your selection of the observational or experimental participants (patients or laboratory animals, including controls) clearly, including eligibility and exclusion criteria and a description of the source population. Because the relevance of such variables as age and sex to the object of research is not always clear, authors should explain their use when they are included in a study report—for example, authors should explain why only participants of certain ages were included or why women were excluded. The guiding principle should be clarity about how and why a study was done in a particular way. When authors use such variables as race or ethnicity, they should define how they measured these variables and justify their relevance.
Methods: Present main experimental procedures, describe repeatable experimental methods, and cite appropriately. Specify the manufacture’s name and address (city and state/country) of materials/equipment used.
The Methods section should include only information that was available at the time the plan or protocol for the study was being written; all information obtained during the study belongs in the Results section.
Technical Information:Identify the methods, apparatus (give the manufacturer’s name and address in parentheses), and procedures in sufficient detail to allow others to reproduce the results. Give references to established methods, including statistical methods (see below); provide references and brief descriptions for methods that have been published but are not well-known; describe new or substantially modified methods, give the reasons for using them, and evaluate their limitations. Identify precisely all drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration.
Authors submitting review manuscripts should include a section describing the methods used for locating, selecting, extracting, and synthesizing data. These methods should also be summarized in the abstract.
Main outcome measures: Indicate the primary study outcome measurement(s), as described in the experimental protocol.
Statistical analysis:Describe statistical methods with enough detail to enable a knowledgeable reader with access to the original data to verify the reported results. When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Avoid relying solely on statistical hypothesis testing, such as P values, which fail to convey important information about effect size. References for the design of the study and statistical methods should be to standard works when possible (with pages stated). Define statistical terms, abbreviations, and most symbols. Specify the computer software used.
Present your results in logical sequence in the text, tables, and figures. Describe from major to minor findings in the sequence of histological, pathological, immunohistochemical, imaging, ethological examination results.
Use illustrations (e.g. graphs, drawing or photographs) where appropriate. Graphs and drawing should be self-explanatory. Do not repeat all the data in the tables or figures in the text; emphasize or summarize only the most important observations. Extra or supplementary materials and technical detail can be placed in an appendix where they will be accessible online but will not interrupt the flow of the text. Insert some photographs respective to histomorphological or pathological changes.
Emphasize the new and important aspects of the study and the conclusions that follow from them in the context of the totality of the best available evidence. Do not repeat in detail data or other information given in the “Introduction” or the “Results” section.
For experimental studies, it is useful to begin the discussion by briefly summarizing the main findings, then explore possible mechanisms or explanations for these findings, compare and contrast the results with other relevant studies, state the limitations of the study, and explore the implications of the findings for future research and for clinical practice.
Link the conclusions with the goals of the study but avoid unqualified statements and conclusions not adequately supported by the data.
Avoid claiming priority or alluding to work that has not been completed. State new hypotheses when warranted, but label them clearly as such.
References should be numbered consecutively in the order in which they are first mentioned. List all authors/editors but if there are more than three, list the first three plus et al. Submitted articles should have a minimum of 50 references.
To minimize citation errors, authors are responsible for verifying all references using either an electronic bibliographic source, such as PubMed or print copies from original sources. If you use a Chinese journal or book which is not indexed in Medline, then use Bopomofo to spell the name.
Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347(4):284-287.
Murray PR, Rosenthal KS, Kobayashi GS, et al. Medical microbiology. 4th ed. St. Louis: Mosby, 2002.
Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, eds. The genetic basis of human cancer. New York: McGraw-Hill. 2002:93-113.
Acknowledgments: Source(s) of support in the form of grants, equipment, drugs, or all of these.
Author Contributions: Identify each author’s contribution to the conception, design, execution, or interpretation of the reported study.
Conflicts of Interest: To prevent potential conflicts of interest from being overlooked or misplaced, this information needs to be part of the manuscript. Print of conflict of interest will be appeared in Supplementary Section of the article published. If there is no conflict of interest, the authors are also required to state that “There are no conflicts of interest to declare.”
Figures and images should be labeled sequentially, numbered and cited in the text. Figure legends should be on a separate sheet titled “Figure legends”. Figures should be referred to specifically in the text of the paper but should not be embedded within the text. If a table or figure has been published before, the authors must obtain written permission to reproduce the material in both print and electronic formats from the copyright owner and submit it with the manuscript.
Use a, b, and c, etc., by alphabetic order of work, if necessary to distinguish between several images appeared in one Figure. Photomicrographs should show magnification and details of any staining techniques used. The area(s) of interest must be clearly indicated with arrows or other symbols.
TIFF and JPEG figure files are acceptable. Figure widths should be no more than 8 cm (single column) and 16 cm (double column). The minimum acceptable resolution is 300 dpi. Line art/charts/graphs should be set in Word or Excel format with compatibility mode.
Figures should be submitted separately as separate files.
Figure legends: Legends must be submitted for all figures. They should be brief and specific, and they should appear on a separate manuscript page after the references. Use scale markers in the image for electron micrographs and indicate. Explain the internal scale and identify the method of staining in photomicrographs.
Tables are numbered in sequence in Arabic numerals (Table 1, 2, etc.), provided with a heading, and referred to in the text as Table 1, Table 2, etc. They should be self-explanatory and should supplement, rather than duplicate, the material in the text. The material in the tables must be ensured consistent with that cited in the relevant places in the text. Including data in tables rather than text frequently makes it possible to reduce the length of the text.
Tables should be included in the manuscript file after figure legends. A legend for each table must be included, which should provide sufficient detail to be intelligible without reference to the text. Legends must define all symbols and include essential information, such as scale bar dimensions. Rather than stating “See text”, legends should be more specific; for example, “See Results”.
Submission of manuscripts
Manuscripts should be submitted online via the CJTER online manuscript submission and review system at www.CRTER.org. For more information, please visit firstname.lastname@example.org and email@example.com or call +86-187 0409 5275/024-23380579/. Once submitted to CJTER, the paper should not be submitted to other journals within 1 months, whether it is undergoing or awaiting the peer review process.
Please upload the following files when you submit your papers.
-A manuscript should include title, author’s institution/affiliation, abstract, key words, introduction, main text, table and figure, acknowledgement and references.
-Recommend 2-4 scientists in the same field to serve as peer reviewers for your paper.
Acceptance and Publication
After acceptance, the authors have access to inquiries into the progress of their paper submitted online using the paper number at any time. Generally, accepted papers will be published within 6-8 months after revision, and authors of grant-funded or first-time publications can apply for publication within 3-4 months after revision.
Transfer of Copyright Agreement
Before publication of your manuscript in CJTER, CJTER must receive your signed Copyright Transfer Agreement Form. All authors should submit a signed agreement, and one designated author may sign on behalf of the other authors. After transfer of copyright, authors retain rights. The Transfer of Copyright Agreement form is available at www.CRTER.org.
In consideration of CJTER’s publication of the manuscript, the authors hereby transfer, assign, and otherwise convey all copyright ownership worldwide, in all languages, and in all forms of media now known or later developed. If CJTER decides for any reason not to publish an author’s submission of the manuscript, CJTER shall give prompt notice of its decision to the corresponding author, this agreement shall terminate, and neither the author nor NRR shall be under any further liability or obligation. For more information, please visit www.CRTER.org.
Anyone interested in reading your research can get free access to your paper at www.CRTER.org. After transfer of copyright, authors retain rights.
Peer Review After Submission
Each paper will be subjected to a strict double-blind peer review by more than 2 peer reviewers from around the world in the same research field. The authors will receive their comments within 4 weeks after submission. The section editors will make a decision to accept, reject, or request a revision or another peer review.
We are committed to providing two journal copies and five high-quality reprints for free with a variety of customizations and delivery options available to you. Our reprints can be purchased as print or electronic reprints, as translated articles, customized to your specific requirements and shrink-wrapped.
1. Abbreviations: Do not use abbreviations in the title and limit them in the text. Spell out all abbreviations (in parentheses) at first mention in the text, unless it is a standard unit of measure.
2. All measurements should be in SI (metric) units.
3. Use generic names for drugs and nonproprietary descriptions of products and equipment.
4. Italics: Genotypes: c-fos, c-myc, etc. Protein produces are set in normal typeface. Biology: Helicobacter pylori, H pylori, E. coli, etc. Latin: in vitro, in situ, et al, etc. Restriction enzymes with the first three letters: EcoRI, Hindl, etc.
5. If any statistical methods are used, the text should state the test or other analytical method applied, basic descriptive statistics, critical value obtained, degrees of freedom, and significance level, e.g. (ANOVA, F = 2.34; df = 3,46; P < 0.01). If a computer data analysis is involved, the software package should be mentioned and specified.
6. Spaces, not commas, should be used to separate thousands and used before and after each unit with the exception of %.
7. In the Abstract, use past tense in METHODS (mostly) and present tense in BACKGROUND and RESULTS AND CONCLUSION (mostly).
8. Units: Laboratory values are expressed using conventional units of measure, with relevant Système International (SI) conversion factors expressed secondarily (in parentheses) only at first mention (e.g., conversion from kPa to mm Hg). Blood cells are counted as ×1012/L, white cells as ×109/L.